Skip to content
Peptide Tracker app iconPeptide Calculator
GLP-1Popular20+ weeks6 phases

Tirzepatide — Standard Titration

20-week ramp: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly

Dose ladder

  2. Phase 1 / 6
    Ramp 1
    Weeks 1–4
    2.5 mg
  4. Phase 2 / 6
    Ramp 2
    Weeks 5–8
    5 mg
  6. Phase 3 / 6
    Ramp 3
    Weeks 9–12
    7.5 mg
  8. Phase 4 / 6
    Ramp 4
    Weeks 13–16
    10 mg
  10. Phase 5 / 6
    Ramp 5
    Weeks 17–20
    12.5 mg
  12. Phase 6 / 6
    Maintenance
    Week 21+
    15 mg

What you'll need

Reference defaults for Tirzepatide — Standard Titration. Your provider may set different values — adjust as needed.

  • Vial
    30 mg
    starting size
  • BAC water
    2 ml
    for reconstitution
  • Concentration
    15.00 mg/ml
    computed
  • Duration
    20+ weeks
    6 phases

How the app runs this for you

  • Auto-advance phases

    Tirzepatide — Standard Titration ramps automatically week by week — no manual tracking. The current phase and remaining weeks are visible on the home tab and the lock-screen widget.

  • Smart reminders

    Per-protocol notifications fire at your chosen time. Missed-dose detection flags any log >15 minutes late, with one-tap resolve from the lock screen.

  • Body-map rotation

    Each log records the injection site. The body map remembers recency so you don't reuse the same spot — especially important on multi-week protocols.

Side effects to watch for

Common in the GLP-1 category. The iOS app lets you track all of these on a timeline and surfaces patterns as your body adapts.

  • Nausea, vomiting, diarrhea, constipation — most pronounced in the first weeks of titration
  • Reduced appetite (the intended effect, but watch for muscle loss without protein intake)
  • Fatigue, headache, dizziness early in titration
  • Rare but serious: pancreatitis, gallbladder issues, severe dehydration

Defaults

Vial size
30 mg
BAC water
2 ml
Concentration
15.00 mg/ml
Total weeks
20+

Uses Tirzepatide. Typical dose range: 2.5–15 mg. Public clinical dosing guidance. Not medical advice.

How Tirzepatide — Standard Titration compares to other GLP-1 protocols

5 protocols compared

Quick read of the dose ladders, durations, and concentrations across the glp-1 category.

ProtocolPeptideDurationPhasesConcentration
Tirzepatide — Standard TitrationPopulartirzepatide20+ weeks615.00 mg/ml
30 mg / 2 ml
Semaglutide — Standard TitrationPopularsemaglutide16+ weeks55.00 mg/ml
10 mg / 2 ml
Semaglutide — Gentle Startsemaglutide16+ weeks35.00 mg/ml
10 mg / 2 ml
Tirzepatide — Aggressivetirzepatide12+ weeks615.00 mg/ml
30 mg / 2 ml
Retatrutide — Escalatingretatrutide16+ weeks410.00 mg/ml
20 mg / 2 ml

Tirzepatide — Standard Titration FAQ

Answers, not hype.

  • Tirzepatide — Standard Titration is a 20-week GLP-1 protocol using Tirzepatide. 20-week ramp: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly

  • The standard cycle is 20+ weeks across 6 dose phases. Phase 1 (Ramp 1) starts at 2.5 mg per dose; the final phase (Maintenance) reaches 15 mg. Individual response and provider guidance can extend or shorten the timeline.

  • Tirzepatide — Standard Titration defaults to a 30 mg vial reconstituted with 2 ml of bacteriostatic water — a concentration of 15.00 mg/ml. The reconstitution calculator on this site lets you adjust to whatever vial size you actually have.

  • Tirzepatide is FDA-approved, and protocols similar to Tirzepatide — Standard Titration appear in the prescribing information. The specific schedule shown here is a starting template — your provider may adjust it based on individual response and tolerability.

  • Most GLP-1 protocols share a common side-effect pattern documented on the parent peptide page. Track them in a timeline view (the iOS app does this automatically) so you can see whether symptoms are settling at the current dose or worsening — that is the signal that determines whether to advance the next phase or hold.

  • No. Tirzepatide — Standard Titration is a reference template summarizing patterns from authoritative sources. It is not a personalized treatment plan. Talk to a licensed healthcare provider before starting, modifying, or stopping any peptide protocol.

More GLP-1 protocols

Run this protocol on autopilot

The iOS app advances this ramp week by week, fires reminders, and keeps a doctor-ready record.

Download on theApp Store